Ep. 230 - Bio€quity Europe 2024 Preview

Next week's Bio€quity Europe conference in San Sebastián will focus on how European biotechs can rise above the noise to attract investors, partners and talent. McKinsey & Co.’s Alexandra Zemp and Paula Olazábal of Ysios Capital joined BioCentury to outline the opportunities and challenges faced by Spain’s biopharma ecosystem and preview some of the conference’s networking events, fireside chats and panel discussions. EBD Group's Claire Macht also joined to detail what to expect in terms of attendees and one-on-one partnering meetings at the event. Bio€quity Europe 2024 is sold out, but space on the waitlist remains, and digital passes are available. See the conference website for more information. View full story: https://www.biocentury.com/article/65237100:00 - Intro03:27 - Spanish Biotech Ecosystem08:13 - McKinsey's Insights12:08 - Event Preview17:26 - BioЄquity Europe C-Level AttendeesReach us by sending a text